Activation of somatostatin receptor (sst5) protects the rat retina from AMPA-induced neurotoxicity

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 297-303

  Kiagiadaki, Foteini ^a   Savvaki, Maria ^a   Thermos, Kyriaki ^a  

^a Faculty of Medicine   (Greece)

Author keywords

Neuropeptides; Neuroprotection; Somatostatin; Somatostatin receptors

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CHOLINE ACETYLTRANSFERASE; L 817818; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RETINA CELL; RETINA INJURY;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMIDES; ANIMALS; CELL DEATH; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FEMALE; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; MALE; NAPHTHALENES; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; RETINA;

EID: 71549125546     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.028     Document Type: Article

References (43)

1. Bigiani A., Petrucci C., Ghiaroni V., Dal Monte M., Cozzi A., Kreienkamp H.J., Richter D., and Bagnoli P. Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Research 29 (2004) 177-185
2. Brandstätter J.H., Koulen P., and Wässle H. Diversity of glutamate receptors in the mammalian retina. Vision Research 38 (1998) 1385-1397
3. Braun H., Schulz S., Becher A., Schroder H., and Hollt V. Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Research 803 (1998) 54-60
4. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., and Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 (1973) 77-79
5. Catalani E., Cervia D., Martini D., Bagnoli P., Simonetti E., Timperio A.M., and Casini G. Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression. European Journal of Neuroscience 25 (2007) 1447-1459
6. Celiker U., and Ilhan N. Nitric oxide and octreotide in retinal ischemia-reperfusion injury. Documenta Ophthalmologica 105 (2002) 327-338
7. Cui Q., and Harvey A.R. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. Journal of Neuroscience 15 (1995) 8143-8155
8. Ferreira I.L., Duarte C.B., and Carvalho A.P. Kainate-induced retina amacrine-like cell damage is mediated by AMPA receptors. Neuroreport 26 (1998) 3471-3475
9. Forloni G., Lucca E., Angeretti N., Chiessa R., and Vezzani A. Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. Journal of Neurochemistry 68 (1997) 319-327
10. Helboe L., and Moller M. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Investigative Ophthalmology and Visual Science 40 (1999) 2376-2382
11. Higgins R.D., Yan Y., and Schrier B.K. Somatostatin analogs inhibit neonatal retinal neovascualrisation. Experimental Eye Research 74 (2002) 553-559
12. Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P.A., O'Carroll A.-M., Patel Y.C., Schonbrunn A., Taylor J.E., and Reisine T. Classification and nomenclature of somatostatin receptors. Trends in Pharmacological Science 16 (1995) 86-88
13. Huang J.C., Salt T.E., Voaden M.J., and Marshall J. Non-competitive NMDA-receptor antagonists and anoxic degeneration of the ERG B-wave in vitro. Eye 5 (1991) 476-580
14. Johnson J., Wu V., Wong H., Walsh J.H., and Brecha N.C. Somatostatin receptor subtype 2A expression in the rat retina. Neuroscience 94 (1999) 675-683
15. Ke J.B., and Zhong Y.M. Expression of somatostatin receptor subtype 5 in rat retinal amacrine cells. Neuroscience 144 (2007) 1025-1032
16. 2 analogs on AMPA-induced neurotoxicity in rat retina. Investigative Ophthalmology and Visual Science 49 (2008) 3080-3089
17. Kouvidi E., Papadopoulou-Daifoti Z., and Thermos K. Somatostatin modulates dopamine release in rat retina. Neuroscience Letters 391 (2006) 82-86
18. 2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends in Neuroscience 30 (2007) 126-134
19. Mastrodimou N., Lambrou G.N., and Thermos K. Effect of somatostatin analogues on chemically induced ischaemia in the rat retina. Naunyn-Schmiederbergs' Archives of Pharmacology 371 (2005) 44-53
20. Mastrodimou N., Kiagiadaki F., and Thermos K. The role of nitric oxide and cGMP in somatostatin's protection against retinal ischemia. Investigative Ophthalmology and Visual Science 49 (2008) 342-349
21. 2+ current modulated by cGMP-dependent protein kinase. Nature 369 (1994) 336-339
22. Olias G., Viollet C., Kusserow H., Epelbaum J., and Meyerhof W. Regulation and function of somatostatin receptors. Journal of Neurochemistry 89 (2004) 1057-1091
23. Osborne N.N., and Larsen A.K. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochemistry International 29 (1996) 263-270
24. Osborne N.N., Larsen A., and Barnett N.L. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells. Investigative Ophthalmology and Visual Science 36 (1995) 1692-1700
25. Osborne N.N., McCord R.J., and Wood J.P.M. The effect of kainate on protein kinase C, GABA, and the uptake of serotonin in the rabbit retina in vivo. Neurochemistry 20 (1995) 635-641
26. Osborne N.N., Casson R.J., Wood J.P., Chidlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Progress of Retinal and Eye Research 21 (2004) 91-147
27. Papadaki T., Tsilimbaris M., Thermos K., Karavellas M., Samonakis D., Papadakis A., Linardakis M., Kouroumalis E., and Pallikaris I. The role of lanreotide in the treatment of choroidal neovascularization secondary to age-related macular degeneration: a pilot clinical trial. Retina 23 (2003) 800-807
28. Papadaki T., Zacharopoulos I., Iaccheri B., Fiore T., and Foster C.S. Somatostatin for uveitic cystoid macular edema (CME). Ocular Immunology and Inflammation 13 (2005) 469-470
29. Reiner P.B., Laycock A.G., and Doll C.J. A pharmacological model of ischemia in the hippocampal slice. Neuroscience Letters 119 (1990) 175-178
30. Robertson J.E., Westra I., Woltering E.A., Winthrop K.L., Barrie R., O'Dorisio T.M., and Holmes D. Intravitreal injection of octreotide acetate. Journal of Ocular Pharmacology and Therapeutics 13 (1997) 171-177
31. Rohrer S.P., Birzin E.T., Mosley R.T., Berk S.C., Hutchins S.M., Shen D.M., Xiong Y., Hayes E.C., Parmar R.M., Foor F., Mitra S.W., Degrado S.J., Shu M., Klopp J.M., Cai S.J., Blake A., Chan W.W., Pasternak A., Yang L., Patchett A.A., Smith R.G., Chapman K.T., and Schaeffer J.M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282 (1998) 737-740
32. Shapiro B., Kronheim S., and Pimstone B. The presence of immunoreactive somatostatin in rat retina. Hormone and Metabolic Research 11 (1979) 79-80
33. Smith L.E.H., Kopchick J.J., Chen W., Knapp J., Kinose F., Daley D., Foley E., Smith R.G., and Schaeffer J.M. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276 (1997) 1706-1709
34. Stroh T., Kreienkamp H.J., and Beaudet A. Immunohistochemical distribution of the somatostatin receptor subtype 5 in the adult rat brain: predominant expression in the basal forebrain. Journal of Comparative Neurology 412 (1999) 69-82
35. Sucher N.J., Lipton S.A., and Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Research 37 (1997) 3483-3493
36. 2+ current in the pituitary cell line AtT-20. Neuroscience 71 (1996) 1073-1081
37. Thermos K. Functional mapping of somatostatin receptors in the retina: a review. Vision Research 43 (2003) 1805-1815
38. Thermos K., Bagnoli P., Epelbaum J., and Hoyer D. The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?. Pharmacology and Therapeutics 110 (2006) 455-464
39. Vasilaki A., and Thermos K. Somatostatin analogues as therapeutics in retinal disease. Pharmacology and Therapeutics 122 (2009) 324-333
40. Vasilaki A., Gardette R., Epelbaum J., and Thermos K. NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Investigative Ophthalmology and Visual Science 42 (2001) 1600-1609
41. Vasilaki A., Mouratidou M., Schulz S., and Thermos K. Somatostatin mediates nitric oxide production by activating sst(2) receptors in the rat retina. Neuropharmacology 43 (2002) 899-909
42. Vasilaki A., Georgoussi Z., and Thermos K. Somatostatin receptors (sst2) are coupled to Go and modulate GTPase activity in the rabbit retina. Journal of Neurochemistry 84 (2003) 625-632
43. Zeevalk G.D., and Nicklas W.J. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. Journal of Pharmacology and Experimental Therapeutics 253 (1990) 1285-1292